This one-year postdoctoral position at AstraZeneca in Gothenburg focuses on developing biocatalytic chemistry and scalable reaction technologies for synthesizing small molecules, investigating clean, atom-efficient approaches that combine hydrogen, hydrogenases and biocatalysts to enable selective reduction and oxidation chemistries. The work involves translating laboratory reactions into robust, scalable industrial processes in collaboration with AstraZeneca scientists and the CirculH2 consortium partners.
The successful candidate will advance enzymatic reaction cascades, optimize reaction conditions, and conduct scale-up studies, including designing experiments that combine organic chemistry principles with biocatalytic development and characterizing products using LC-MS, GC-MS, and NMR.
Candidates must hold a PhD within five years or be doctoral students graduating within six months of joining, with a strong publication record and experience in independent research; familiarity with enzyme cascades, high-throughput screening, and sustainable chemistry principles is preferred.
Text as published by the employer. Always confirm details on the employer's site.